Sign in
or
Join FriendFeed
FriendFeed
is the easiest way to share online.
Learn more »
Join FriendFeed
649
subscriptions
670
subscribers
7,767
comments
3,881
likes
Sally Church
Interested in Pharma, Biotech, Science and cancer... Find me at
http://www.pharmastrategyblog.com
also love food, wine, the NFL and cricket. Hi!
more »
Subscribe
to Sally Church
ASH 2012 update on ARRY-520 in multiple myeloma -
http://pharmastrategyblog.com/2013...
March 1
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Will biomarkers revolutionalise treatment with tivozanib? -
http://pharmastrategyblog.com/2013...
February 25
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
ASCO GU update on tivozanib in advanced clear cell renal cancer -
http://pharmastrategyblog.com/2013...
February 21
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Tumor Lysis Syndrome – what is it and why is it important in cancer research? -
http://pharmastrategyblog.com/2013...
February 18
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Making a difference in Advanced Prostate Cancer – an interview with Bertrand Tombal -
http://pharmastrategyblog.com/2013...
February 15
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Making a difference in pancreatic cancer – an interview with Dr Hedy Lee Kindler -
http://pharmastrategyblog.com/2013...
February 12
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Will ASCO GI herald a new era for pancreatic cancer? -
http://pharmastrategyblog.com/2013...
January 24
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Effectively targeting KRAS in lung cancer with a MEK inhibitor -
http://pharmastrategyblog.com/2012...
November 29
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Time to rethink cancer clinical trials strategy? -
http://pharmastrategyblog.com/2012...
November 27
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Zaltrap – a simple dosing error or not? -
http://pharmastrategyblog.com/2012...
November 9
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Free Software
liked this
Update on KRAS in pancreatic cancer -
http://pharmastrategyblog.com/2012...
October 12
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Prospect of Abraxane in Pancreatic Cancer excites ESMO 2012 -
http://pharmastrategyblog.com/2012...
September 30
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on bavituximab in non-squamous lung cancer -
http://pharmastrategyblog.com/2012...
September 11
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
ASCO 2012 Update 2: Overcoming resistance in metastatic melanoma -
http://pharmastrategyblog.com/2012...
June 29, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
A surfeit of riches in CLL and NHL: on bruton kinase and PI3K delta inhibitors -
http://pharmastrategyblog.com/2012...
June 27, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
ASCO 2012 Update 1: Advanced Lung Cancer -
http://pharmastrategyblog.com/2012...
June 26, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Interested in the PI3K-AKT-mTOR pathway in cancer research? -
http://pharmastrategyblog.com/2012...
June 20, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Aggregating the 2012 ASCO tweets -
http://pharmastrategyblog.com/2012...
June 1, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on advanced prostate cancer including enzalutamide (MDV3100) and abiraterone -
http://pharmastrategyblog.com/2012...
May 25, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Stunning data with dabrafenib (BRAFV600E) in metastatic melanoma and brain metastases -
http://pharmastrategyblog.com/2012...
May 22, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Reflections of a Medical Oncologist on AACR 2012 -
http://pharmastrategyblog.com/2012...
May 18, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
ASCO 2012 Preview – Highlights of key data emerging from Chicago -
http://pharmastrategyblog.com/2012...
May 15, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
ASCO 2012 Acronym Mania! -
http://pharmastrategyblog.com/2012...
May 14, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Ribonucleases (RNase) – clinical applications for cancer therapy -
http://pharmastrategyblog.com/2012...
May 1, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Ribonucleases (RNase) what are they and why are they relevant to cancer? -
http://pharmastrategyblog.com/2012...
April 30, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Highlights of AACR 2012 – Part 3 -
http://pharmastrategyblog.com/2012...
April 23, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Highlights of AACR 2012 – Part 2 -
http://pharmastrategyblog.com/2012...
April 18, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Highlights of AACR 2012 – Part 1 -
http://pharmastrategyblog.com/2012...
April 17, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
American Society for Cancer Research Meeting 2012 -
http://pharmastrategyblog.com/2012...
March 31, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
On adaptive mechanisms of crizotinib resistance in ALK-positive lung cancer -
http://pharmastrategyblog.com/2012...
March 23, 2012
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Best of week from Sally Church
-
Older items »
Other ways to read this feed: